Press Releases

May 02, 2019
Meeting activities include presentations of Phase 3 data, cannabinoid education for clinicians, and a virtual reality experience CARLSBAD, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), the world leader in the development and